Examining the use of QbD approaches to explore clinically relevant design space

• In: S6 - Implementation of Quality by Design and Risk Management- overcoming the practical hurdles on Thursday, 4 September 2008, 09:00-12:00
• At: Basel (Switzerland) (2008)
• Type: Presentation
• By: TOWNSEND, Andrew (AstraZeneca, United States of America)
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login